Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Norris Medicines Ltd.
Swot
Norris Medicines Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Norris Medicines Ltd. has 11 Strengths, 9 Weaknesses, 0 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(11)
Weakness
(9)
Opportunity
(0)
Threats
(1)
Others
(1)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 2 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Company with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Weak Momentum: Price below Short, Medium and Long Term Averages
Increasing Trend in Non-Core Income
RSI indicating price weakness
Top Losers
Red Flags: Weakening Technicals and Share Price Decline
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
